Cagrilintide/semaglutide
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
Novo Nordisk · Phase 3 · Withdrawn · Enrollment 0
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| CagriSema B in device 2 + Placebo in device 1 | n/r | n/r | n/r | n/r | n/r |
| CagriSema in device 1 + Placebo in device 2 | n/r | n/r | n/r | n/r | n/r |
| Placebo in device 1 + Placebo in device 2 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.